NASDAQ
Beam Therapeutics Inc. (BEAM) has a fcf yield of -13.13% as of Monday, August 3, 2026. This represents a 79.08% decrease compared to its 12-month average of -7.33%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.